Latest by Myles Helfand

As Senate Health Care Vote Looms, HIV Groups Raise Alarm

The U.S. Senate publicly unveiled its version of the American Health Care Act on June 22. Many HIV advocacy organizations, health care groups and community leaders have expressed staunch opposition.

By Myles Helfand and Ken Stockwell

On HIV Long-Term Survivors Awareness Day, a Community Speaks Out

This grassroots effort honors people who have been living with HIV for more than 10 years, and seeks to combat stigma and discrimination by educating the public about what it means to live -- and grow older -- with HIV today.

By Myles Helfand and Ken Stockwell

Jeers From HIV Community Greet Trump's Detailed Budget Proposal

The Trump administration released the first detailed version of its proposed federal budget on May 23. Leading organizations within the HIV community were quick to condemn it.

By Myles Helfand

Is Your HIV Treatment Working? Warning Signs and False Alarms

The first few months after starting HIV treatment are pivotal in determining whether your first regimen will be successful. Yet, if you are brand new to HIV treatment, how can you tell what success is?

By Myles Helfand and Benjamin Young, M.D., Ph.D.

HIV Treatment Adherence: Recently Asked Questions

Missed a dose? Pondering a treatment break? Worried about HIV medication access while traveling? Top HIV doctors answer your questions in our "Ask the Experts" forums.

By Myles Helfand

Healing HIV's 'Viral Divide' Will Take Time and Empathy, Latinx Journalist Says

The "viral divide" is shrinking thanks to recent advances in HIV prevention, journalist and activist Mathew K. Rodriguez contends. However, a great deal of healing still needs to take place, he said in a wide-ranging Facebook Live interview.

By Myles Helfand

Can PrEP Limit My HIV Treatment Options if I Become Positive?

HIV expert Joel Gallant, M.D., M.P.H., recently tackled the question: "How high is the resistance risk if PrEP is inadvertently started during an acute infection?"

By Myles Helfand

Early Doses, Late Doses, Extra Doses, Missed Doses: What's the Risk? An HIV Doc Responds

Adherence imperfection is one of the more common concerns we hear about from people taking once-daily HIV treatment regimens. They want to know: What's the penalty of a missed or late HIV medication dose?

By Myles Helfand

Which First-Line HIV Treatment Regimen Is Least Toxic? An HIV Doc Responds

In areas with easy access to HIV medications, people have a wealth of regimens to choose from that work well and are unlikely to cause serious side effects. In fact, sometimes, it can feel like there are too many choices.

By Myles Helfand

How to Locate HIV/AIDS Services Near You

Whether you're looking for information or assistance, and whether your needs are HIV testing, health care, medication access, mental health, housing or connecting with others, there's an organization out there that can help.

By Myles Helfand